New Jersey's 5th congressional district representative, Josh Gottheimer, has been active in the stock market, according to a recent congressional trade report. The report details multiple transactions carried out through a Morgan Stanley (NYSE:MS) - Select UMA Account.
Gottheimer has purchased stocks from several companies, including 3M Company (NYSE:MMM), Abbott Laboratories (NYSE:ABT), Alibaba Group Holding Limited (NYSE:BABA), and Ambev S.A. (NYSE:ABEV). Each of these purchases falls within the $1,001 - $15,000 range.
In addition to these purchases, the congressman also invested in stocks from Berkshire Hathaway Inc . (NYSE:BRKa) (NYSE:BRK.B), Cadre Holdings , Inc. (NYSE:CDRE), Coca-Cola Company (NYSE:KO), and Corning Incorporated (NYSE:GLW). All these investments also fall within the $1,001 - $15,000 range. With a market capitalization of $81.26 billion and a P/E ratio of 19.79, 3M demonstrates solid fundamentals. InvestingPro subscribers have access to over 10 additional exclusive insights and detailed financial metrics for each of these companies.
The report also reveals that Gottheimer has sold off part of his stakes in several companies. These include Alphabet (NASDAQ:GOOGL) Inc. (NASDAQ:GOOG), Arista Networks , Inc. (NYSE:ANET), Broadcom Inc. (NASDAQ:AVGO), and Eaton Corporation, PLC (NYSE:ETN). Each of these partial sales is also valued between $1,001 and $15,000.
However, one transaction stood out from the rest. Gottheimer sold off his full stake in Merck (NSE:PROR) & Company, Inc. (NYSE:MRK), valued between $15,001 and $50,000.
The transactions were all conducted in January 2025, with the notification date being February 6, 2025.
The report provides a glimpse into the investment strategies of one of the members of Congress. However, it's essential to remember that these transactions do not necessarily reflect the congressman's views on the companies involved or their future performance in the stock market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.